Your browser doesn't support javascript.
loading
Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.
Jones, Gieira S; Hoadley, Katherine A; Benefield, Halei; Olsson, Linnea T; Hamilton, Alina M; Bhattacharya, Arjun; Kirk, Erin L; Tipaldos, Heather J; Fleming, Jodie M; Williams, Kevin P; Love, Michael I; Nichols, Hazel B; Olshan, Andrew F; Troester, Melissa A.
Afiliação
  • Jones GS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 253 Rosenau Hall, CB #7435, 135 Dauer Drive, Chapel Hill, NC, 27599-7400, USA.
  • Hoadley KA; Department of Genetics, University of North Carolina-Chapel Hill-Chapel Hill, Chapel Hill, USA.
  • Benefield H; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
  • Olsson LT; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 253 Rosenau Hall, CB #7435, 135 Dauer Drive, Chapel Hill, NC, 27599-7400, USA.
  • Hamilton AM; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 253 Rosenau Hall, CB #7435, 135 Dauer Drive, Chapel Hill, NC, 27599-7400, USA.
  • Bhattacharya A; Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill, Chapel Hill, USA.
  • Kirk EL; Department of Biostatistics, University of North Carolina-Chapel Hill, Chapel Hill, USA.
  • Tipaldos HJ; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA.
  • Fleming JM; Institute for Quantitative and Computational Biosciences, David Geffen School of Medicine, University of California, Los Angeles, USA.
  • Williams KP; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 253 Rosenau Hall, CB #7435, 135 Dauer Drive, Chapel Hill, NC, 27599-7400, USA.
  • Love MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
  • Nichols HB; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
  • Olshan AF; Department of Biological and Biomedical Sciences, North Carolina Central University, Durham, USA.
  • Troester MA; Biomanufacturing Research Institute and Technology Enterprise, North Carolina Central University, Durham, USA.
Breast Cancer Res Treat ; 192(2): 447-455, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35034243

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fator de Crescimento de Hepatócito Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fator de Crescimento de Hepatócito Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos